ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 235

MRI in Rheumatoid Arthritis: Does Quantifying the Number of Erosive Lesions Improve Detection of Subtle Erosive Progression Compared to the Omeract RA MRI Scoring System?

Ulf Sundin1, Anna-Birgitte Aga2, Tore K Kvien3, Siri Lillegraven4 and Espen A. Haavardsholm4, 1*Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Diakonhjemmet Hospital, Oslo, Norway, 4Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Early Rheumatoid Arthritis, MRI, Outcome measures, radiology and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Early detection of erosive progression is an important application of MRI in RA. For research purposes the OMERACT Rheumatoid Arthritis MRI Scoring system (RAMRIS) is commonly applied, with semi-quantitative assessment of erosive volume. However, over time new erosive lesions can occur without sufficient increase in volume to result in a higher score. This could allow for subtle erosive progression to go undetected. We aimed to examine if quantifying the number of erosions in addition to erosive volume could provide improved sensitivity to change.

Methods: In a cohort consisting of 84 patients, all fulfilling the 1987 ACR criteria for RA, with disease duration of < 1 year, MRI of the dominant wrist was acquired at 0, 3, 6, and 12 months. A trained reader, blinded for patient data, scored the MRI images in known chronological order according to the RAMRIS method. In addition, we registered the number of erosive lesions at each site. The 78 patients who had completed at least the baseline and 6- or 12-month exams were by each method identified as either progressors or non-progressors, using an increase of 1 unit as cut-off value. The results were compared using cross tables and Spearman correlation.

Results: The median baseline age (25th, 75th percentile) was 58.1 (47.3, 66.4) years, disease duration was 107 (70, 186) days, 77% were female, and 55% were anti-CCP positive. Median baseline RAMRIS erosion score was 8 (5, 11) and the median number of MRI erosions was 10 (6, 14). Median 1 year change in RAMRIS erosion score was 1 (0, 2), and median change in number of erosions was 1 (0, 2). Both methods identified an equal number of patients as progressors, and agreement was observed in 82% of cases. Seven patients were progressors by the RAMRIS method only and 7 by the counting erosive lesions method only (table). The Spearman correlation coefficient of the two scores was 0.75, p<0.001 (figure).  

 

Conclusion: The RAMRIS erosion score was generally low, both with respect to baseline level as well as progression rate. By supplementing the assessment with quantification of the number of erosive lesions, we could in this material identify a limited number of additional patients as progressors. Further longitudinal studies could show to what extent patients with this type of early minimal erosive lesions on MRI progress on conventional radiographs, and if this is clinically important.


Disclosure: U. Sundin, None; A. B. Aga, None; T. K. Kvien, AbbVie, 2,Pfizer Inc, 2,Roche Pharmaceuticals, 2,UCB, 2,BMS, 2,MSD, 2,AbbVie, 5,Pfizer Inc, 5,BMS, 8,MSD, 8,Roche Pharmaceuticals, 8,UCB, 8,AbbVie, 8; S. Lillegraven, None; E. A. Haavardsholm, None.

To cite this abstract in AMA style:

Sundin U, Aga AB, Kvien TK, Lillegraven S, Haavardsholm EA. MRI in Rheumatoid Arthritis: Does Quantifying the Number of Erosive Lesions Improve Detection of Subtle Erosive Progression Compared to the Omeract RA MRI Scoring System? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/mri-in-rheumatoid-arthritis-does-quantifying-the-number-of-erosive-lesions-improve-detection-of-subtle-erosive-progression-compared-to-the-omeract-ra-mri-scoring-system/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mri-in-rheumatoid-arthritis-does-quantifying-the-number-of-erosive-lesions-improve-detection-of-subtle-erosive-progression-compared-to-the-omeract-ra-mri-scoring-system/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology